[EVALUATION OF METABOLIC AND CLINICAL EFFECTS FOLLOWING PROLONGED ADMINISTRATION OF BETA-BENZALBUTYRRAMIDE IN ATHEROSCLEROTIC PATIENTS].
D000924:Anticholesteremic Agents; D001161:Arteriosclerosis; D002087:Butyrates; D006801:Humans
D000924:Anticholesteremic Agents; D002087:Butyrates
ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; BUTYRATES
VALUTAZIONE DEGLI EFFETTI METABOLICI E CLINICI CONSEGUENTI A SOMMINISTRAZIONE PROLUNGATA DI BETA-BENZALBUTIRRAMIDE IN PAZIENTI ATEROSCLEROTICI.